Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4271)
All Articles published online
|
Feb 14, 2010 (publication date) through May 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Menakongka A, Suthiphongchai T. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. World J Gastroenterol 2010; 16(6): 713-722 [PMID: 20135719 DOI: 10.3748/wjg.v16.i6.713] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i6/713.htm |
| Number | Citing Articles |
| 1 |
Ingvild J. Brusevold, Monica Aasrum, Magne Bryne, Thoralf Christoffersen. Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI‐3 kinase/Akt. Journal of Oral Pathology & Medicine 2012; 41(7): 547 doi: 10.1111/j.1600-0714.2012.01139.x
|
| 2 |
Sonali Ghosh, Moitri Basu, Sib Sankar Roy. ETS-1 Protein Regulates Vascular Endothelial Growth Factor-induced Matrix Metalloproteinase-9 and Matrix Metalloproteinase-13 Expression in Human Ovarian Carcinoma Cell Line SKOV-3. Journal of Biological Chemistry 2012; 287(18): 15001 doi: 10.1074/jbc.M111.284034
|
| 3 |
WEI YANG, XIAOYUAN WANG, WEI ZHENG, KEDONG LI, HAOFENG LIU, YUEMING SUN. Genetic and epigenetic alterations are involved in the regulation of TPM1 in cholangiocarcinoma. International Journal of Oncology 2013; 42(2): 690 doi: 10.3892/ijo.2012.1741
|
| 4 |
Srinivasa P Pothula, Zhihong Xu, David Goldstein, Andrew V Biankin, Romano C Pirola, Jeremy S Wilson, Minoti V Apte. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. British Journal of Cancer 2016; 114(3): 269 doi: 10.1038/bjc.2015.478
|
| 5 |
Yulei Gu, Zhiqiang Zhu, Hui Pei, Dong Xu, Yumin Jiang, Luanluan Zhang, Lili Xiao. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging 2020; 12(3): 2333 doi: 10.18632/aging.102747
|
| 6 |
Henan Zhang, Sarah M. Jenkins, Chuang-Ta Lee, Susan M. Harrington, Zhuogang Liu, Haidong Dong, Lizhi Zhang. Bim is an independent prognostic marker in intrahepatic cholangiocarcinoma. Human Pathology 2018; 78: 97 doi: 10.1016/j.humpath.2018.04.009
|
| 7 |
Xianxiu Ge, Youli Wang, Yun Wang, Quanpeng Li, Hong Yu, Lin Miao. NK4 Gene Therapy Inhibits HGF/Met-Induced Growth of Human Cholangiocarcinoma Cells. Digestive Diseases and Sciences 2013; 58(6): 1636 doi: 10.1007/s10620-012-2523-7
|
| 8 |
Sumera I. Ilyas, Gregory J. Gores. Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology 2013; 145(6): 1215 doi: 10.1053/j.gastro.2013.10.013
|
| 9 |
Amir A. Rahnemai-Azar, Allison Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis. Surgical Oncology 2017; 26(2): 125 doi: 10.1016/j.suronc.2016.12.009
|
| 10 |
Kesara Na-Bangchang, Tullayakorn Plengsuriyakarn, Juntra Karbwang. Research and Development ofAtractylodes lancea(Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics. Evidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/5929234
|
| 11 |
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Disease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
|
| 12 |
Chao Yan, Stephane Koda, Jing Wu, Bei‐Bei Zhang, Qian Yu, Mihai G. Netea, Ren‐Xian Tang, Kui‐Yang Zheng. Roles of Trained Immunity in the Pathogenesis of Cholangiopathies: A Therapeutic Target. Hepatology 2020; 72(5): 1838 doi: 10.1002/hep.31395
|
| 13 |
Supak Yothaisong, Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, Puangrat Yongvanit, Vajarabhongsa Bhudhisawasdi, Anucha Puapairoj, Gregory J. Riggins, Watcharin Loilome. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Tumor Biology 2013; 34(6): 3637 doi: 10.1007/s13277-013-0945-2
|
| 14 |
Growth Factors and Their Receptors in Cell Differentiation, Cancer and Cancer Therapy. 2011; : 249 doi: 10.1016/B978-0-12-387819-9.00029-3
|
| 15 |
Thannicha Sae-lao, Natthanej Luplertlop, Tavan Janvilisri, Rutaiwan Tohtong, David O. Bates, Kanokpan Wongprasert. Sulfated galactans from the red seaweed Gracilaria fisheri exerts anti-migration effect on cholangiocarcinoma cells. Phytomedicine 2017; 36: 59 doi: 10.1016/j.phymed.2017.09.014
|
| 16 |
MARÍA ÁNGELES TRILLO, MARÍA ANTONIA MARTÍNEZ, MARÍA ANTONIA CID, ALEJANDRO ÚBEDA. Retinoic acid inhibits the cytoproliferative response to weak 50-Hz magnetic fields in neuroblastoma cells. Oncology Reports 2013; 29(3): 885 doi: 10.3892/or.2012.2212
|
| 17 |
Cheong A. Bae, In-Hye Ham, Hye Jeong Oh, Dagyeong Lee, Jongsu Woo, Sang-Yong Son, Jung Hwan Yoon, James B. Lorens, Rolf A. Brekken, Tae-Min Kim, Sang-Uk Han, Won Sang Park, Hoon Hur. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma. Gastric Cancer 2020; 23(5): 824 doi: 10.1007/s10120-020-01066-4
|
| 18 |
Alphonse E Sirica, Deanna J Campbell, Catherine I Dumur. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Current Opinion in Gastroenterology 2011; 27(3): 276 doi: 10.1097/MOG.0b013e32834405c3
|
| 19 |
Kittiya Supradit, Boonyakorn Boonsri, Jinchutha Duangdara, Thanvarin Thitiphatphuvanon, Chinnawut Suriyonplengsaeng, Thaned Kangsamaksin, Tavan Janvilisri, Rutaiwan Tohtong, Kiren Yacqub-Usman, Anna M. Grabowska, David O. Bates, Kanokpan Wongprasert. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis. Toxicology in Vitro 2022; 82: 105385 doi: 10.1016/j.tiv.2022.105385
|
| 20 |
Wenwei Liao, Qingbo Feng, Huixian Liu, Jinpeng Du, Xiangzheng Chen, Yong Zeng. Circular RNAs in cholangiocarcinoma. Cancer Letters 2023; 553: 215980 doi: 10.1016/j.canlet.2022.215980
|
| 21 |
Vincent Marchese, Jazmin Juarez, Priyal Patel, Dorothy Hutter-Lobo. Density-dependent ERK MAPK expression regulates MMP-9 and influences growth. Molecular and Cellular Biochemistry 2019; 456(1-2): 115 doi: 10.1007/s11010-019-03496-w
|
| 22 |
Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate, Jittiyawadee Sripa, Panthip Rattanasinganchan, Pornphimon Metheenukul, Rutaiwan Tohtong. In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma. Molecules 2022; 27(14): 4664 doi: 10.3390/molecules27144664
|
| 23 |
Panagiotis Papoutsoglou, Corentin Louis, Cédric Coulouarn. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma. Cells 2019; 8(9): 960 doi: 10.3390/cells8090960
|
| 24 |
William S. Holland, Danielle C. Chinn, Primo N. Lara, David R. Gandara, Philip C. Mack. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. Journal of Cancer Research and Clinical Oncology 2015; 141(4): 615 doi: 10.1007/s00432-014-1855-4
|
| 25 |
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48798-8
|
| 26 |
Maria Trovato, Maria Luisa Torre, Marta Ragonese, Angela Simone, Rosy Scarfì, Valeria Barresi, Giuseppe Giuffrè, Salvatore Benvenga, Flavio F. Angileri, Giovanni Tuccari, Francesco Trimarchi, Rosaria Maddalena Ruggeri, Salvatore Cannavò. HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. Endocrine 2013; 44(3): 735 doi: 10.1007/s12020-013-9950-x
|
| 27 |
Fang Liu, Shasha Song, Zhi Yi, Min Zhang, Jiali Li, Fang Yang, Hongtao Yin, Xiufeng Yu, Chao Guan, Ying Liu, Zizhen Liu, Jing Wang, Daling Zhu. HGF induces EMT in non-small-cell lung cancer through the hBVR pathway. European Journal of Pharmacology 2017; 811: 180 doi: 10.1016/j.ejphar.2017.05.040
|
| 28 |
Phaijit Sritananuwat, Natthaporn Sueangoen, Parichut Thummarati, Kittiya Islam, Tuangporn Suthiphongchai. Blocking ERK1/2 signaling impairs TGF-β1 tumor promoting function but enhances its tumor suppressing role in intrahepatic cholangiocarcinoma cells. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0454-2
|
| 29 |
Alphonse E. Sirica. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology 2012; 9(1): 44 doi: 10.1038/nrgastro.2011.222
|
| 30 |
Xiu-juan LI, Xiao-peng YANG, Guang-ming WAN, Yu-ying WANG, Jin-song ZHANG. Expression of hepatocyte growth factor and its receptor c-Met in lensinduced myopia in guinea pigs. Chinese Medical Journal 2013; 126(23): 4524 doi: 10.3760/cma.j.issn.0366-6999.20131889
|
| 31 |
Ulrike Schmidt, Gerwin Heller, Gerald Timelthaler, Petra Heffeter, Zsolt Somodi, Norbert Schweifer, Maria Sibilia, Walter Berger, Agnes Csiszar. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01862-5
|
| 32 |
Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. Gene Expression 2018; 18(1): 31 doi: 10.3727/105221617X15088670121925
|
| 33 |
Yang Yang, Xueting Deng, Quanpeng Li, Fei Wang, Lin Miao, Qi Jiang. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges. Cancer Communications 2020; 40(12): 655 doi: 10.1002/cac2.12109
|
| 34 |
Pirawan Poosekeaw, Chawalit Pairojkul, Banchob Sripa, Prakasit Sa Ngiamwibool, Sitthichai Iamsaard, Chadamas Sakonsinsiri, Raynoo Thanan, Piti Ungarreevittaya, Konradin Metze. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma. PLOS ONE 2021; 16(11): e0259075 doi: 10.1371/journal.pone.0259075
|
| 35 |
Simone Radtke, Mina Milanovic, Carine Rossé, Manu de Rycker, Sylvie Lachmann, Andrew Hibbert, Stéphanie Kermorgant, Peter J. Parker. ERK2 but not ERK1 mediates HGF-induced motility in non small cell lung carcinoma cell lines. Journal of Cell Science 2013; doi: 10.1242/jcs.115832
|
| 36 |
Kittiya Islam, Parichut Thummarati, Pakkanun Kaewkong, Banchob Sripa, Tuangporn Suthiphongchai. Role of laminin and cognate receptors in cholangiocarcinoma cell migration. Cell Adhesion & Migration 2021; 15(1): 152 doi: 10.1080/19336918.2021.1924422
|
| 37 |
Daisaku Yamada, Sumera Rizvi, Nataliya Razumilava, Steven F. Bronk, Jaime I. Davila, Mia D. Champion, Mitesh J. Borad, Jorge A. Bezerra, Xin Chen, Gregory J. Gores. IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism. Hepatology 2015; 61(5): 1627 doi: 10.1002/hep.27687
|
| 38 |
Keatdamrong Janpipatkul, Kanoknetr Suksen, Suparerk Borwornpinyo, Natee Jearawiriyapaisarn, Suradej Hongeng, Pawinee Piyachaturawat, Arthit Chairoungdua. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration. Cellular Signalling 2014; 26(8): 1668 doi: 10.1016/j.cellsig.2014.04.002
|
| 39 |
Shigeyoshi Honma, Sachina Takasaka, Takahiro Ishikawa, Takahiro Shibuya, Satoru Mitazaki, Sumiko Abe, Makoto Yoshida. Effect of brefelamide on HGF-induced survival of 1321N1 human astrocytoma cells. In Vitro Cellular & Developmental Biology - Animal 2016; 52(6): 705 doi: 10.1007/s11626-016-0019-z
|
| 40 |
Jennifer A. Sanders, Philip A. Gruppuso. Translation and Its Regulation in Cancer Biology and Medicine. 2014; : 611 doi: 10.1007/978-94-017-9078-9_30
|
| 41 |
Yu‐Pan Bai, Kun Shang, Huan Chen, Fei Ding, Zhen Wang, Chen Liang, Ye Xu, Meng‐Hong Sun, Ying‐Yi LI. FGF‐1/‐3/FGFR4 signaling in cancer‐associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP‐7. Cancer Science 2015; 106(10): 1278 doi: 10.1111/cas.12745
|
| 42 |
Soraya Salas-Silva, Arturo Simoni-Nieves, María Valeria Razori, Jocelyn López-Ramirez, Jonatan Barrera-Chimal, Roberto Lazzarini, Oscar Bello, Verónica Souza, Roxana U. Miranda-Labra, María Concepción Gutiérrez-Ruiz, Luis Enrique Gomez-Quiroz, Marcelo G. Roma, Leticia Bucio-Ortiz. HGF induces protective effects in α-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress. Biochemical Pharmacology 2020; 174: 113812 doi: 10.1016/j.bcp.2020.113812
|
| 43 |
Antonello A. Romani, Silvia Desenzani, Marina M. Morganti, Maria Cristina Baroni, Angelo F. Borghetti, Paolo Soliani. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid. Cancer Chemotherapy and Pharmacology 2011; 67(3): 557 doi: 10.1007/s00280-010-1345-6
|
| 44 |
Allyson K. Martínez, Kendal Jensen, Chad Hall, April O'Brien, Laurent Ehrlich, Tori White, Fanyin Meng, Tianhao Zhou, John Greene, Francesca Bernuzzi, Pietro Invernizzi, David E. Dostal, Terry Lairmore, Gianfranco Alpini, Shannon S. Glaser. Nicotine Promotes Cholangiocarcinoma Growth in Xenograft Mice. The American Journal of Pathology 2017; 187(5): 1093 doi: 10.1016/j.ajpath.2017.01.011
|
| 45 |
Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. Cells 2019; 8(10): 1172 doi: 10.3390/cells8101172
|
| 46 |
Jun Hu, Baobing Yin. Advances in biomarkers of biliary tract cancers. Biomedicine & Pharmacotherapy 2016; 81: 128 doi: 10.1016/j.biopha.2016.02.045
|
| 47 |
Jesus M. Banales, Vincenzo Cardinale, Guido Carpino, Marco Marzioni, Jesper B. Andersen, Pietro Invernizzi, Guro E. Lind, Trine Folseraas, Stuart J. Forbes, Laura Fouassier, Andreas Geier, Diego F. Calvisi, Joachim C. Mertens, Michael Trauner, Antonio Benedetti, Luca Maroni, Javier Vaquero, Rocio I. R. Macias, Chiara Raggi, Maria J. Perugorria, Eugenio Gaudio, Kirsten M. Boberg, Jose J. G. Marin, Domenico Alvaro. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology 2016; 13(5): 261 doi: 10.1038/nrgastro.2016.51
|
| 48 |
Runping Liu, Renping Zhao, Xiqiao Zhou, Xiuyin Liang, Deanna J.W. Campbell, Xiaoxuan Zhang, Luyong Zhang, Ruihua Shi, Guangji Wang, William M. Pandak, Alphonse E. Sirica, Phillip B. Hylemon, Huiping Zhou. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 2014; 60(3): 908 doi: 10.1002/hep.27085
|
| 49 |
Roland Kaufmann, Alexander Hascher, Franziska Mußbach, Petra Henklein, Kathrin Katenkamp, Martin Westermann, Utz Settmacher. Proteinase-activated receptor 2 (PAR2) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level. Histochemistry and Cell Biology 2012; 138(6): 913 doi: 10.1007/s00418-012-1006-4
|
| 50 |
Daniel Walden, Selvi Kunnimalaiyaan, Kevin Sokolowski, T. Clark Gamblin, Muthusamy Kunnimalaiyaan. Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma. Oncotarget 2017; 8(50): 88069 doi: 10.18632/oncotarget.21422
|
| 51 |
Marutpong Detarya, Kanlayanee Sawanyawisuth, Chaiwat Aphivatanasiri, Sriwipa Chuangchaiya, Paksiree Saranaruk, Lukkana Sukprasert, Atit Silsirivanit, Norie Araki, Sopit Wongkham, Chaisiri Wongkham. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. Glycobiology 2020; 30(5): 312 doi: 10.1093/glycob/cwz098
|
| 52 |
Hao Peng, Erwei Zhu, Yewei Zhang. Advances of cancer-associated fibroblasts in liver cancer. Biomarker Research 2022; 10(1) doi: 10.1186/s40364-022-00406-z
|